triMSx educational meeting
Wednesday 2 September 2020
| 19:00-20:30 BST | 14:00-15:30 EST | 20:00-21:30 CEST
People with multiple sclerosis continue to face increased risks and challenges in light of the COVID-19 pandemic. As many countries begin to move out of isolation, there are many unanswered questions.
We encourage you to participate by joining us live and posing your questions to the experts during the panel discussion
triMS.online would like to acknowledge Merck KGaA, Darmstadt, Germany for providing an independent medical education grant for this triMSx event
00:00:00 | Welcome |
00:04:59 | Case study 1 |
00:16:04 | Polling, discussion and Q&A |
00:44:56 | Case study 2 |
00:57:23 | Polling, discussion and Q&A |
01:23:04 | Meeting close |
19:00 |
Welcome
|
19:05 |
Case study 1Do we know how immune responses to SARS-CoV-2 are affected by DMTs?
Case study to be presented by:
|
19:15 |
Polling, discussion and Q&A
Panellists for Q&A:
|
19:45 |
Case study 2
To shield or not to shield: its impact, and vaccine readiness
Case study to be presented by:
|
19:55 | Polling, discussion and Q&A
Panellists for Q&A:
|
20:25 |
Meeting close
|
![]() |
Speaker biographies0.4MB PDF |